Identification of complement inhibitors and complement regulatory proteins in ABO-incompatible compare with HLA-incompatible kidney transplantatio

• Conditions: ABOi kidney transplantationHLAi kidney transplantation; Accommodation; ABO incompatibility or ABO incompatible kidney transplantation; Complement regulatory proteins; Complement inhibitors; HLA incompatibility or HLA incompatible kidney transplantation; Kidney transplantation

• Registration Number: TCTR20210904002
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-09-04
• Study Completion: 2021-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Transplantation patients in King Chulalongkorn Memorial Hospital
2. Patients who ever had kidney biopsy

Exclusion Criteria

1. Contraindication for kidney biopsy
2. Recurrent glomerular disease
3. Urinary tract infection

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Complement inhibitors 12 months PCR

Secondary Outcome Measures

Name	Time	Method
Complement regulatory proteins 12 months PCR